Novozymes chairs EU project
Bagværd - The Danish biotech company Novozymes A/S and the Freiburg-based Max-Planck-Institute of immunobiology will chair a European Comission project looking into animal-free testing of products' allergy potential. The so-called “Sens-it-iv” project will run from 2006 to 2010 with 31 participants in 11 states and is aimed at investigating in vitro alternatives to the use of animal experiments.
The Commission has earmarked Euro11 million for the project. Novozymes, a comany dealing with enzymes and microorganisms, will co-ordinate ten working groups focusing on areas as diverse as chemicals and proteins, artificial tissues, immune cells and bioinformatics. Another job will be to bring together existing data on in vitro testing from disparate sources into a single database.